← Back to Search

Procedure

Fetoscopic Repair for Gastroschisis

N/A
Recruiting
Led By Sundeep Keswani, MD
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during first month of life
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test a new surgery for unborn babies with severe bowel issues where their intestines are outside their belly. The surgery is done through a small opening in the mother's womb using a camera and tiny tools. This method hopes to reduce complications after birth compared to traditional treatments.

Who is the study for?
This trial is for pregnant women over 18 with a single pregnancy between 20-25 weeks, where the fetus has gastroschisis. Candidates must have normal genetic tests and no significant unrelated anomalies or maternal health issues that could complicate surgery.
What is being tested?
The study is testing the safety and feasibility of repairing complex gastroschisis in unborn babies using fetoscopy—a surgical procedure performed on the fetus. The aim is to see if this can reduce death and complications after birth.
What are the potential side effects?
Potential side effects are not explicitly listed, but may include risks associated with fetal surgery such as preterm labor, infection, or complications from anesthesia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at hospital discharge, an average of 1.5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at hospital discharge, an average of 1.5 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Successful Repair of Complex Gastroschisis
Secondary study objectives
Bronchopulmonary Dysplasia
Central Line Associated Bloodstream Infection (CLABSI)
Intracranial hemorrhage
+13 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: fetoscopic surgical repairExperimental Treatment1 Intervention
Single arm study. All patients will receive the fetoscopic repair.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatment for Gastroschisis involves surgical repair, typically performed after birth, to return the exposed intestines to the abdominal cavity and close the abdominal wall defect. The trial studying fetoscopic surgical repair aims to perform this correction in utero, hypothesizing that early intervention can reduce postnatal mortality and morbidity. This approach matters for Gastroschisis patients as it may prevent complications associated with prolonged exposure of the intestines to amniotic fluid, such as inflammation and damage, potentially leading to better overall outcomes and reduced need for extensive postnatal care.

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor
1,023 Previous Clinical Trials
6,029,271 Total Patients Enrolled
Sundeep Keswani, MDPrincipal InvestigatorBaylor College of Medicine and Texas Children's Hospital

Media Library

Fetal Repair of Complex Gastroschisis (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05704257 — N/A
Abdominal Wall Defects Research Study Groups: fetoscopic surgical repair
Abdominal Wall Defects Clinical Trial 2023: Fetal Repair of Complex Gastroschisis Highlights & Side Effects. Trial Name: NCT05704257 — N/A
Fetal Repair of Complex Gastroschisis (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05704257 — N/A
~7 spots leftby Dec 2029